Covid-19 roundup: Eli Lilly's RA drug gets solo OK from FDA; Emergent gets greenlight to resume manufacturing at Bayview site
The FDA late Wednesday extended the EUA for Eli Lilly’s rheumatoid arthritis drug Olumiant (baricitinib) to be used as a solo …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
